PROLOR Biotech, Inc. is relocating its corporate office and R&D facility to a new, larger building located near its current site in the Weizmann Science Park in Nes Ziona, Israel.

The new headquarters and upgraded R&D facility comprise approximately 10,000 sq. ft. of leased space, allowing for growth in all areas, including new drug research and clinical development. The expanded R&D facility includes clean rooms for GMP-grade production of therapeutic drug candidates for the production of a variety of therapeutic proteins for R&D applications.

“We are excited that this move gives us the opportunity to upgrade our R&D facility, allowing for the planned expansion in R&D headcount and activity needed to accomplish the ambitious goals we have set for our clinical development and research programs in 2011 and 2012,” said Shai Novik, president of PROLOR. “This new facility makes it possible for us to strengthen our capabilities across the board, and we intend to leverage it fully to help accomplish our stated milestones.”